MarketWatch: Pharmaceutical reform in South Korea and the lessons it provides

Hak Ju Kim, Jennifer Prah Ruger

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Through implementation of its 2000 pharmaceutical reform, the South Korean government expected to reduce the cost of medications and improve service levels, medical appropriateness of care, and drug effectiveness. However, despite the reform's lofty goals, unintended consequences have distorted the supply of medical services and spending. These consequences have included increasing the use of uninsured services, prescribing high-price drugs, and a growing market share for multinational drug companies. Further reforms are needed to reduce the measure's adverse effects. This paper examines the Korean mandatory prescription system and offers an analysis of Korea's reforms.

Original languageEnglish
Pages (from-to)w260-w269
JournalHealth Affairs
Volume27
Issue number4
DOIs
StatePublished - Jul 2008

Fingerprint

Dive into the research topics of 'MarketWatch: Pharmaceutical reform in South Korea and the lessons it provides'. Together they form a unique fingerprint.

Cite this